| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 13.13B | 11.62B | 13.28B | 13.09B | 14.16B | 13.91B |
| Gross Profit | 4.46B | 4.12B | 4.52B | 4.42B | 4.64B | 4.51B |
| EBITDA | 2.01B | 1.55B | 1.81B | 1.83B | 1.75B | 1.79B |
| Net Income | 708.56M | 504.57M | 765.33M | 797.07M | 723.94M | 755.92M |
Balance Sheet | ||||||
| Total Assets | 31.62B | 32.06B | 31.74B | 32.44B | 30.88B | 31.33B |
| Cash, Cash Equivalents and Short-Term Investments | 4.57B | 4.74B | 4.55B | 4.64B | 4.43B | 5.03B |
| Total Debt | 12.57B | 12.60B | 12.55B | 13.70B | 12.62B | 13.39B |
| Total Liabilities | 14.55B | 14.76B | 14.67B | 15.85B | 14.74B | 15.53B |
| Stockholders Equity | 17.06B | 17.29B | 17.07B | 16.59B | 16.14B | 15.80B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 462.18M | 1.19B | -1.02B | 645.18M | 844.58M |
| Operating Cash Flow | 0.00 | 1.36B | 2.71B | 793.95M | 1.29B | 1.60B |
| Investing Cash Flow | 0.00 | -1.04B | -1.44B | -1.13B | -903.58M | -446.41M |
| Financing Cash Flow | 0.00 | -259.40M | -1.30B | 653.01M | -1.17B | -869.55M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥33.71B | 8.76 | ― | 3.86% | 18.56% | 86.25% | |
71 Outperform | ¥36.77B | 5.76 | ― | 3.01% | 7.25% | 36.43% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
63 Neutral | ¥41.75B | 7.74 | ― | 6.02% | -5.07% | -26.79% | |
62 Neutral | ¥2.84T | 7.65 | 11.39% | 2.93% | 2.61% | 10.15% | |
59 Neutral | ¥6.18B | 12.20 | 2.90% | 4.53% | -12.48% | -34.07% | |
56 Neutral | ¥55.61B | 11.83 | 6.98% | 7.35% | 9.08% | -42.76% |